You can buy or sell VTL and other stocks, options, ETFs, and crypto commission-free!
Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. Read More The company was founded in May 2003 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Stock Price, News, & Analysis for Vital Therapies
Vital Therapies, Inc., a biotherapeutic company, focuses on developing and commercializing a cell-based therapy for the treatment of acute forms of liver failure in the United States. Its product candidate is the ELAD system, an extracorporeal human allogeneic cellular liver therapy that is in Phase III clinical trials helps in enhancing the rates of survival in patients with acute forms of liver failure. The company was formerly known as Vitagen Acquisition Corp. and changed its name to Vital Therapies, In...
Expected May 7, After Hours